Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
HotStart™ 2X Green qPCR Master Mix for High-Precision qPCR
2026-08-06
HotStart™ 2X Green qPCR Master Mix delivers highly specific, reproducible SYBR Green qPCR results through antibody-mediated Taq polymerase inhibition. Its robust formulation enables accurate gene expression analysis and nucleic acid quantification across diverse applications.
-
Fe3O4@ZIF-8 Nanoparticles: Antibacterial and Osteogenic Stra
2026-08-06
This study presents a multifunctional nanoplatform—Fe3O4@ZIF-8 nanoparticles—for treating jaw osteomyelitis, combining potent antibacterial effects with bone regeneration capabilities. The findings highlight how controlled Zn2+ release disrupts bacterial membranes and proteostasis, while Fe3O4 supports osteogenesis, offering a promising translational approach to persistent infection and bone defect repair.
-
CGP 55845 Hydrochloride: Precision GABAB Receptor Antagonist
2026-08-05
CGP 55845 hydrochloride empowers researchers to dissect GABAB receptor-mediated neurotransmitter modulation with high specificity in in vitro models. Its robust pharmacology and compatibility with advanced synaptic transmission assays make it an essential tool for unraveling astrocyte-driven mechanisms in the hippocampal dentate gyrus.
-
RNASEH1-AS1: Prognostic lncRNA Target in Hepatocellular Carc
2026-08-05
This study identifies the long non-coding RNA RNASEH1-AS1 as an independent biomarker and oncogenic factor in hepatocellular carcinoma (HCC), highlighting its association with poor prognosis and immune regulation. Comprehensive transcriptomic and experimental analyses reveal RNASEH1-AS1's mechanistic links to cancer progression and its value for future diagnostic and therapeutic strategies.
-
Bioluminescent Probes for Immunoproteasome: Synthesis and As
2026-08-04
The reference study introduces a caged bioluminescent probe selective for the immunoproteasome (iCP), enabling rapid and specific activity assays in live cells. This innovation addresses the need for improved tools to study iCP in disease contexts and facilitates future small-molecule screening and mechanistic research.
-
Applied Workflows with 10 mM dNTP Mixture for DNA Synthesis
2026-08-04
Unlock reproducible, high-fidelity DNA synthesis by leveraging the APExBIO 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture. This guide distills protocol enhancements, troubleshooting, and integrative insights from recent advances in intracellular trafficking and nucleic acid delivery. Empower your PCR, sequencing, and DNA assembly workflows with actionable, evidence-based strategies.
-
Sitagliptin Phosphate Monohydrate: DPP-4 Inhibitor Workflows
2026-08-03
Explore how Sitagliptin phosphate monohydrate enables precise incretin hormone modulation and advanced metabolic disease modeling. Discover optimized protocols, troubleshooting strategies, and experimental insights anchored by the latest gut-brain research.
-
D-Luciferin Potassium Salt: Strategic Insights for Translati
2026-08-03
This article delivers a thought-leadership perspective on D-Luciferin (potassium salt) as a pivotal tool for translational researchers. By interweaving mechanistic understanding, experimental design, and clinical relevance, it provides strategic guidance for deploying bioluminescence imaging in advanced disease models—distinguishing itself from standard product overviews.
-
Next-Generation mRNA Assays with EZ Cap™ Firefly Luciferase
2026-08-02
Discover how EZ Cap™ Firefly Luciferase mRNA elevates mRNA delivery and translation efficiency assays with robust Cap 1 structure, advanced stability, and unprecedented assay reliability. This in-depth analysis unpacks the latest innovations and practical strategies for molecular biology workflows.
-
YM 58483 (BTP2): Mechanistic Insights for SOCE Blockade in F
2026-08-01
Explore advanced mechanistic insights into YM 58483 (BTP2), a potent SOCE inhibitor, and its impact on calcium signaling and fibrosis research. This article uniquely bridges molecular action with translational assay optimization, providing actionable guidance for researchers.
-
Baicalin Methyl Ester Restores Intestinal Barrier via P65 Pa
2026-07-31
This study elucidates how baicalin methyl ester, an esterified derivative of baicalin, mitigates LPS-induced intestinal barrier damage in mice and MODE-K cells. The research highlights BME's modulation of the P65/TNF-α/MLCK/ZO-1 pathway, providing mechanistic insight into its anti-inflammatory and barrier-protective roles.
-
DiscoveryProbe™ Metabolism-related Compound Library: Protoco
2026-07-31
The DiscoveryProbe™ Metabolism-related Compound Library (SKU L1032) provides researchers with 493 validated, cell-permeable compounds for systematic metabolic pathway interrogation. It is optimized for high-throughput metabolic enzyme inhibition assays and pathway studies but is not suitable for diagnostic or clinical applications. Researchers benefit most when following established compound management and QC protocols.
-
Diterpene JXE-23 Induces Autophagy and Cell Cycle Arrest in
2026-07-30
A 2024 study reports the isolation of ent-8(14),15-pimaradiene-2β,19-diol (JXE-23) from Aleuritopteris albofusca, showing selective cytotoxicity in hepatocellular carcinoma (HCC) cells by inducing G2/M arrest and protective autophagy. These findings highlight JXE-23 as a promising lead for anticancer drug research and reinforce the value of natural diterpenes in targeting HCC cell survival pathways.
-
Sulfisomidine in Translational Research: Clinical Insights a
2026-07-30
Explore Sulfisomidine’s pivotal role as both a short-acting sulfonamide antibacterial agent and a precision tool for enzyme kinetics inhibitor studies. This article uniquely bridges historical clinical insights with contemporary biochemical and translational workflows.
-
10 mM dNTP Mixture: Optimizing DNA Synthesis and Delivery
2026-07-29
Unlock reproducible, high-fidelity DNA synthesis and advanced nucleic acid delivery with the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture from APExBIO. Discover actionable workflow enhancements and troubleshooting strategies grounded in recent mechanistic insights into nanoparticle-mediated delivery.